ºÚÁÏÍø

Skip to main content
  • Ross Boyce, MD, MSc

    Dr. Boyce Receives $4.4 Million to Lead a Malaria Intervention Project in Uganda Following Extreme Weather Events

    The NIH has awarded a multi-disciplinary team led by Ross Boyce, MD, MSc, a $4.4 million, five-year (R01) grant to evaluate the effectiveness of a chemoprevention effort designed to prevent malaria outbreaks after flooding, using a combination of interventions. Boyce is a member of the Institute for Global Health and Infectious Diseases (IGHID), an Assistant Professor in the Divi … Read more

  • Five NC Institutions Collaborating to Advance Kidney, Urology, Hematology (KUH) Research

    Ronald Falk, MD, Nan and Hugh Cullman Eminent Professor of Medicine at ºÚÁÏÍø, Anthony Atala, MD, Professor of Medicine at Wake Forest University and Thomas Ortel, MD, PhD, Professor of Medicine at Duke University, will lead an effort to cultivate a highly skilled cohort of people and resources to advance research in kidney, urology, and hematology. Collaboration in medicine is comm … Read more

  • Angela Wahl, PhD, Balfour Sartor MD, and J. Victor Garcia, PhD, and colleagues created a germ-free mouse model to evaluate the role of the microbiome in the infection, replication, and pathogenesis of HIV and Epstein-Barr virus. 

  • MacNider Building

    Study Shows Weight Loss Drug Reduces Cardiovascular Risk by 20% in Overweight, Obese Adults

    A new study shows semaglutide 2.4 mg (Wegovy), a weekly injected prescription medication for overweight adults, may prevent major adverse cardiovascular events (MACEs) such as cardiovascular death, non-fatal heart attack or non-fatal stroke. Novo Nordisk released the results of the significant clinical trial called SELECT. The trail studied the effects of Wegovy on people with ca … Read more

  • Evan S. Dellon, MD, MPH

    Dr. Dellon Ushers in First FDA-Approved Medication for Eosinophilic Esophagitis

    Evan Dellon, MD, MPH, a professor of medicine in the Division of Gastroenterology & Hepatology and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for the treatment in adults and adolescents with eosinophilic esophagitis. Eosinophilic esophagitis (EoE) is an allergic condition of the esophagus that is on th … Read more

  • Lone star tick research

    Using Collaboration to Fight a Tricky Tick-Borne Disease

    A Lone star tick next to forceps Alpha-Gal Syndrome, or AGS, is a recently identified tick-borne disease that triggers an allergy to red meat and other products made from mammals, including cheese, gelatin, and medications like heparin. Since its discovery in 2009, cases in the United States alone have risen from 24 to >40,000 people, owing to the geographic spread of the tick … Read more

  • TARC Holds Fifth Annual “Research Day”

    Approximately 100 leading researchers and clinicians, research staff and trainees gathered recently to discuss innovative ways to advance research in arthritis, allergy, and autoimmune diseases. Additionally, attendees who couldn’t participate in person attended remotely. Of particular interest this year was keynote speaker and John B. Winfield, MD Visiting Scholar, Ali Ellebedy, … Read more

  • Seth Berkowitz, MD, MPH

    Dr. Seth A. Berkowitz earns Hettleman Prize for Artistic and Scholarly Achievement

      Seth Berkowitz, MD, MPH Seth A. Berkowitz, MD, MPH, an associate professor in the Division of General Medicine and Clinical Epidemiology in the Department of Medicine, is one of four ºÚÁÏÍø faculty members awarded the 2022 Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement. The Hettleman Prizes were established in 1986 by the late Phillip Hettleman, a mem … Read more

  • Two Popular Diabetes Drugs Outperform Two Others in Head-to-Head Comparison

    Dr. John Buse and colleagues complete first study comparing commonly used medications for type 2 diabetes Diabetes affects more than one out of every ten Americans and about one out of every three people in their lifetime. John Buse, MD, PhD Type 2 diabetes occurs when the pancreas does not produce enough insulin — a hormone that regulates the movement of sugars, carbohydrates, o … Read more

  • Wahl Receives $3.2 Million to Study the Neurological Consequences of HIV Infection

    Angela Wahl, PhD Angela Wahl, PhD, an assistant professor in the Division of Infectious Diseases in the Department of Medicine, and a member of the Institute for Global Health & Infectious Diseases (IGHID), has received a $3.2 million R01 award to study the role of microglia in HIV latency and persistence in the brain. Over 38 million people are living with HIV worldwide. Whi … Read more

  • waltmann-meshnick-scaled-e1656101391554-1024x793

    Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

    Andreea Waltmann and the late Steve Meshnick. Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for intermittent preventive therapy of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, de … Read more

  • ºÚÁÏÍø Physician Scientists Training Program Gives Awards to Cultivate the Careers of Upcoming Physician-Scientists

    Medicine, like any other scientific field, cannot progress forward without the hard work of new, cutting-edge researchers. In the Department of Medicine, three physician scientist trainees are working to improve the lives of patients who have inflammatory bowel disease, cancer, and food allergies. In light of their promising, hard work, all three have received support from the UN … Read more